Latest Regulatory Approvals News

Alterity Therapeutics has won a new US composition of matter patent for its lead drug ATH434, extending intellectual property protection to at least 2045 and boosting its commercial potential ahead of Phase 3 trials in Multiple System Atrophy.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

Maritana Minerals has secured key regulatory approvals and is progressing critical non-process infrastructure at its Black Swan Processing Hub, keeping the project on track for first gold production in the second half of 2027.

Resouro Strategic Metals has closed its $2.5 million private placement, issuing 10 million shares at 25 cents each to support the environmental program and feasibility study for its Tiros project in Brazil.

Black Horse Mining Limited completed an $8 million IPO and acquired an 80% stake in the Mt Egerton Gold Project holder. The company reported a $5.87 million loss for FY26, driven by exploration costs and significant share-based payments.

Acrow Limited has secured Phase 1 clearance from the ACCC for its AusGroup Industrial Services acquisition, removing a key regulatory hurdle and setting the stage for completion by the end of August.

Accelerate Resources' gravity survey reveals structural controls aligning with high-grade manganese outcrops at Woodie Woodie North, enhancing targeting for a maiden drill campaign.

Pioneer Minerals has identified a high-priority bedrock electromagnetic conductor adjacent to the historic Springfield Tungsten Mine in Idaho, refining drill targets ahead of its maiden drilling campaign.

Newmont and Barrick have settled all disputes related to their Nevada Gold Mines joint venture, agreeing to contribute previously excluded properties and updating governance terms. Newmont will pay Barrick $1.95 billion, while also consenting to Barrick's proposed North American gold assets IPO.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

Bank of Queensland announces a $295 million capital return combining a fully franked 15-cent special dividend and a $196 million on-market buy-back following the sale of its equipment finance portfolio and completion of ME digital migration.

Minerals Exploration Limited has reported rock chip assays with gold grades up to 37.4 g/t and tungsten up to 2.63% at its Glenorchy Tungsten Project in Otago, New Zealand. The company plans a maiden drilling program in late 2026, pending regulatory approvals.